OPEN END TURBO BULL OPTIONSSCHEIN - ASTRAZENECA | Market Closed - BOERSE MUENCHEN 20:45:42 31/05/2024 BST | ||
| 2.36 EUR | +9.26% |
|
| Current month | +5.83% | ||
| 1 month | +5.83% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ASTRAZENECA PLC
Latest news about ASTRAZENECA PLC
| Date | Price | Change |
|---|---|---|
| 31/05/24 | 2.36 | +9.26% |
| 30/05/24 | 2.16 | +5.88% |
| 29/05/24 | 2.04 | -3.32% |
| 28/05/24 | 2.11 | -17.90% |
| 27/05/24 | 2.57 | +3.21% |
Real-time BOERSE MUENCHEN
Last update May 31, 2024 at 08:45 pm
More quotesStatic data
| Product type | Certificat Turbo |
|---|---|
| Buy / Sell | CALL |
| Underlying | ASTRAZENECA PLC |
| Issuer | 
UniCredit
|
| WKN | HD3JRS |
| ISIN | DE000HD3JRS8 |
| Date issued | 08/03/2024 |
| Strike | 10,213 p |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.31 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.65 € |
|---|---|
| Lowest since issue | 0.2 € |
| Spread | 0.06 € |
| Spread % | 2.47% |
Company Profile
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows:
- product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases);
- collaboration revenue (4.4%).
Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).
Sector
-
Consensus: AstraZeneca PLC
Sell
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
155.1
USD
Average target price
172
USD
Spread / Average Target
+10.90%
- Stock Market
- Certificates
- Certificat
